![ALPROLIX® [coagulation factor IX (recombinant), Fc fusion protein], lyophilized powder for solution for intravenous injection. Prescribing Information ALPROLIX® [coagulation factor IX (recombinant), Fc fusion protein], lyophilized powder for solution for intravenous injection. Prescribing Information](https://products.sanofi.us/Alprolix/alp0b-0002-01.jpg)
ALPROLIX® [coagulation factor IX (recombinant), Fc fusion protein], lyophilized powder for solution for intravenous injection. Prescribing Information
![ALPROLIX® [coagulation factor IX (recombinant), Fc fusion protein], lyophilized powder for solution for intravenous injection. Prescribing Information ALPROLIX® [coagulation factor IX (recombinant), Fc fusion protein], lyophilized powder for solution for intravenous injection. Prescribing Information](https://products.sanofi.us/Alprolix/alp0b-0002-03.jpg)
ALPROLIX® [coagulation factor IX (recombinant), Fc fusion protein], lyophilized powder for solution for intravenous injection. Prescribing Information
![ALPROLIX® [coagulation factor IX (recombinant), Fc fusion protein], lyophilized powder for solution for intravenous injection. Prescribing Information ALPROLIX® [coagulation factor IX (recombinant), Fc fusion protein], lyophilized powder for solution for intravenous injection. Prescribing Information](https://products.sanofi.us/Alprolix/alp0b-0002-04.jpg)
ALPROLIX® [coagulation factor IX (recombinant), Fc fusion protein], lyophilized powder for solution for intravenous injection. Prescribing Information
![ALPROLIX® [coagulation factor IX (recombinant), Fc fusion protein], lyophilized powder for solution for intravenous injection. Prescribing Information ALPROLIX® [coagulation factor IX (recombinant), Fc fusion protein], lyophilized powder for solution for intravenous injection. Prescribing Information](https://products.sanofi.us/Alprolix/alp0b-0002-02.jpg)
ALPROLIX® [coagulation factor IX (recombinant), Fc fusion protein], lyophilized powder for solution for intravenous injection. Prescribing Information
![Frontiers | Status of Recombinant Factor VIII Concentrate Treatment for Hemophilia A in Italy: Characteristics and Clinical Benefits Frontiers | Status of Recombinant Factor VIII Concentrate Treatment for Hemophilia A in Italy: Characteristics and Clinical Benefits](https://www.frontiersin.org/files/Articles/484310/fmed-06-00261-HTML-r1/image_m/fmed-06-00261-t003.jpg)